Related Experiment Videos
Risk stratification by accelerated high-dose dipyridamole stress echocardiography in patients over 70 years of age
Liz Andréa Villela Baroncini1, Leonardo Brandão Précoma1, Cintia Doná Busato2
1Center of Health and Biological Sciences, Pontificia Universidade Católica do Paraná, Rua Imaculada Conceição, 1155, Prado Velho, CEP: 80215-901 Curitiba, Paraná, Brazil.
Insights
Accelerated high-dose dipyridamole stress echocardiography is feasible for assessing coronary artery disease risk in older adults. A positive stress echo response, coronary artery disease, and dyslipidemia predict cardiovascular events, while male gender and positive stress echo predict death.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Geriatric Medicine
Background:
- Non-invasive prognostic assessment of coronary artery disease (CAD) is crucial in patients over 70.
- Accurate risk stratification in this elderly population is a significant clinical challenge.
Purpose of the Study:
- To evaluate the feasibility, predictive values, and accuracy of accelerated high-dose dipyridamole stress echocardiography.
- To assess its utility in patients aged 70 years and older.
Main Methods:
- Retrospective analysis of 379 patients (mean age 75.9 years) undergoing dipyridamole stress echocardiography.
- Follow-up data for 313 patients over a mean of 21 months.
- Statistical analysis including logistic regression and Cox regression models.
Main Results:
- High feasibility (97%) of the procedure in elderly patients.
- Excellent negative predictive values (96.7-97.7%) and accuracy (94.9-95.5%) for cardiovascular events.
- Positive predictive values of 30% (6 months) and 40% (12 months).
- Independent predictors of cardiovascular events included dyslipidemia, CAD, and positive stress echo response.
- Male gender and positive stress echo response predicted mortality.
Conclusions:
- Accelerated high-dose dipyridamole stress echocardiography is a feasible method for risk stratification in patients over 70.
- Positive stress echo response, CAD, and dyslipidemia are significant predictors of cardiovascular events.
- Male gender and positive stress echo response are significant predictors of death in this cohort.
Background:
The non-invasive prognostic assessment of coronary artery disease in patients over 70 years old is an important goal in daily clinical practice.
Objectives:
To retrospectively assess the feasibility, the positive and negative predictive values and the accuracy of accelerated high-dose dipyridamole stress echocardiography in patients over 70 years old.
Methods:
Three hundred seventy nine patients (226 women; mean age of 75.9±4.6 years) underwent dipyridamole stress echocardiography.
Results:
Follow-up data were available for 313 patients (mean follow-up duration 21±15.7 months). Overall feasibility was 97%. Positive predictive values were 30% and 40% for 6 and 12 months of follow-up, respectively. Negative predictive values were 97.7% and 96.7% for 6 and 12 months of follow-up, respectively. Accuracy values were 95.5% and 94.9% for 6 and 12 months of follow-up, respectively. Among the clinical variables, dyslipidemia (OR 5.3; CI 95% 1.3-20.9; p=0.016), coronary artery disease (OR 4.2; CI 95% 1.3-13.3; p=0.014) and a positive stress echo response (OR 9.0; CI 95% 1.7-49.1; p=0.011) were independently associated with the occurrence of a cardiovascular event. A Cox regression model showed that male gender and a positive stress echo response significantly predicted death.
Conclusions:
Risk stratification with accelerated high-dose dipyridamole stress echocardiography is feasible in patients over 70 years old. A positive stress echo response, the presence of coronary artery disease, and dyslipidemia positively predicted the occurrence of cardiovascular events. Male gender and a positive stress echo response significantly predicted death.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Drug Dosing: Geriatric Patients
Cardiomyopathy II: Dilated Cardiomyopathy